Abstract
At the injection site in the foot pad a chronic ulcerative lesion develops due to the adjuvant, and the regional popliteal lymph node is grossly enlarged. If supportive care is provided, most animals recover from acute experimental allergic encephalomyelitis and the extent of the central inflammatory process decreases gradually.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adda DH, Beraud E, Depieds R (1977) Evidence for suppressor cells in Lewis rats’ experimental allergic encephalomyelitis. Eur J Immunol 7: 620–623
Antel J, Oger JJ, Jackevicius S, Kuo HH, Arnason BGW (1982) Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis. Proc Natl Acad Sci USA 79: 3330–3334
Arnon R (1981) Experimental allergic encephalomyelitis: susceptibility and suppression. Immunol Rev 55: 5–30
Ben-Nun A, Cohen IR (1981) Vaccination against autoimmune encephalomyelitis (EAE): attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line. Eur J Immunol 11: 949–952
Ben-Nun A, Cohen IR (1982) Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 129: 303–308
Ben-Nun A, Ron Y, Cohen IR (1980) Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature 288: 389–390
Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11:195–199
Bolton C, Borel JF, Cuzner ML, Davison AN, Turner AM (1982a) Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis. J Neurol Sci 56:147–153
Bolton C, Allsopp G, Cuzner ML (1982b) The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol 47:127–132
Bolton C, Borel JF, Cuzner ML, Davison AN, Turner AM (1982c) Autoimmunity: cyclosporin A therapy in experimental allergic encephalomyelitis. In: White DJG (ed) Cyclosporin A. Elsevier Biomedical, Amsterdam, pp 135–142
Borel JF (1981) Pharmacology and pharmacokinetics of cyclosporin A. In: Touraine JL et al. (eds) Transplantation and clinical immunology, vol 13. Excerpta Medica, Amsterdam, pp 3–6
Borel JF (ed) (1986) Cyclosporin. Prog Allergy 38: 9–18
Borel JF, Lafferty KJ (1983) Cyclosporine: speculation about its mechanism of action. Transplant Proc 15: 1881–1885
Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6: 468–475
Bowern N, Ramshaw IA, Clark IA, Doherty PC (1984) Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med 160:1532–1543
Brandriss MW (1963) Methotrexate: suppression of experimental allergic encephalomyelitis. Science 140: 186–187
Brosnan CF, Wisniewski HM (1980) Immunopathology of allergic encephalomyelitis. In: Batistin L, Hashim G, Lajtha A (eds) Neurochemistry and clinical neurology. Liss, New York, pp 379–390 (Progress in clinical and biological research series, vol 39)
Brosnan CF, Cammer W, Norton WT, Bloom BR (1980) Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 285: 235–237
Brosnan CF, Bornstein MB, Bloom BR (1981) The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126: 614–620
Brosnan CF, Goldmuntz EA, Cammer W, Factor SM, Bloom BR, Norton WT (1985) Prazosin, an (alpha)r adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Proc Natl Acad Sci USA 82: 5915–5919
Brosnan CF, Sacks HJ, Goldschmidt RC, Goldmuntz EA, Norton WT (1986) Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol 137:3451–3456
Brown A, McFarlin DE, Raine CS (1982) Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest 46:171–185
Cammisuli S, Feurer C (1984) The effect of cyclosporin-A and dihydrocyclosporin-D on the therapy and prophylaxis of experimental allergic encephalomyelitis. Prog Clin Biol Res 146: 415–421
Davison AN, Cuzner ML (1980) The suppression of experimental allergic encephalomyelitis and multiple sclerosis. Academic, London
DeFreitas EC, Sandberg-Wollheim M, Schonely K, Boufal M, Koprowski H (1986) Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients. Proc Natl Acad Sci USA 83: 2637–2641
Feurer C, Prentice DE, Cammisuli S (1985) Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. J Neuroimmunol 10:159–166
Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307: 273–276
Fredane LM, Hashim GA, McCabe RE (1983) The effect of cyclosporine on lymphocyte subsets in experimental allergic encephalomyelitis. Functional loss of diseasesuppressing cells in vivo. Transplant Proc (Suppl) 15: 2909–2913
Fritz RB, Chou CHJ, McFarlin DE (1983) Relapsing murine allergic encephalomyelitis induced by myelin basic protein. J Immunol 130:1024–1026
Goldmuntz EA, Brosnan CF, Norton WT (1986) Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental auto immune encephalomyelitis in the Lewis rat. J Immunol 137: 3444–3450
Hauser SL, Weiner HL, Che M, Shapiro ME, Gilles F, Letvin NL (1984) Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. J Immunol 132:1276–1281
Hayosh NS, Swanborg RH (1986) Autoimmune effector cells. VII. Cells isolated from thymus and spinal cord of rats with experimental allergic encephalomyelitis transfer disease. Am J Pathol 122:218–222
Hickey WF, Gonatas NK (1984) Suppressor T-lymphocytes in the spinal cord of Lewis rats recovered from acute experimental allergic encephalomyelitis. Cell Immunol 85: 284–288
Hinrichs DJ, Roberts CM, Waxman FJ (1981) Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. J Immunol 126: 1857–1862
Hinrichs DJ, Wegmann KW, Peters BA (1983) The influence of cyclosporin A on the development of actively induced and passively transferred experimental allergic encephalomyelitis. Cell Immunol 77: 202–209
Holda JH, Swanborg RH (1981) Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats. Eur J Immunol 11: 338–340
Hommes OR, Lamers KJB, Reekers P (1980) Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis. J Neurol 223:177–190
Hoyer LW, Good RA, Condie RM (1962) Experimental allergic encephalomyelitis: the effect of 6-mercaptopurine. J Exp Med 116: 311–327
Kabat EA, Wolf A, Bezer AE (1952) Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. VII. Effect of cortisone. J Immunol 68:265–275
Keith AB (1978) Sex difference in Lewis rats in the incidence of recurrent experimental allergic encephalomyelitis. Nature 272: 824–825
Lemire JM, Weigle WO (1986) Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions. J Immunol 137: 3169–3174
Linthicum DS, Munoz JJ, Blaskett A (1982) Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol 73: 299–310
Lublin FD, Maurer PH, Berry RG, Tippett D (1981) Delayed, relapsing, experimental allergic encephalomyelitis in mice. J Immunol 126: 819–822
McCarron RM, Spatz M, Kempski O, Hogan RN, Muehl L, McFarlin DE (1986) Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol 137: 3428–3435
McFarlin DE, McFarland HF (1982) Multiple sclerosis. N Engl J Med 307:1183–1188,1246-1251
McFarlin D, Blank SE, Kibler RF (1974) Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol 113:712–715
McKhann GM (1982) Multiple sclerosis. Annu Rev Neurosci 5: 219–239
Mokhtarian F, McFarlin D, Raine CS (1984) Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309: 356–359
Paterson PY (1978) Autoimmune neurological disease: experimental animal systems and implications for multiple sclerosis. In: Talal N (ed) Autoimmunity: genetic, immunologic, virologic and clinical aspects. Academic, New York, pp 644–691
Paterson PY, Beisaw NE (1963) Effect of whole body xirradiation on induction of allergic encephalomyelitis in rats. J Immunol 90: 532–539
Paterson PY, Drobish DG (1969) Cyclosphosphamide. Effect on experimental allergic encephalomyelitis in Lewis rats. Science 165:191–192
Paterson PY, Hanson MA (1969) Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats. J Immunol 103:1311–1316
Peters BA, Hinrichs DJ (1982) Passive transfer of experimental allergic encephalomyelitis in the Lewis rat with activated spleen cell: differential activation with mitogens. Cell Immunol 69: 175–185
Raine CS (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50: 608–635
Raine CS, Stone SH (1977) Animal model for multiple sclerosis: chronic experimental allergic encephalomyelitis in inbred guinea pigs. NY State J Med 77: 1693–1696
Raine CS, Mokhtarian F, McFarlin DE (1984) Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest 51: 534–546
Ryffel B, Feurer C, Heuberger B, Borel JF (1982) Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment. Immunobiology 163: 470–483
Saka K, Namikawa T, Kunishita T, Yamanouchi K, Tabira T (1986) Studies of experimental allergic encephalomyelitis by using encephalitogenic T cell lines and clones in euthymic and athymic mice. J Immunol 137: 1527–1531
Schluesener HJ, Lassmann H (1985) Recombinant interleukin 2 (IL-2) promotes T cell line-mediated neuroautoimmune disease. J Neuroimmunol 11: 87–91
Schnyder B, Weber E, Fierz W, Fontana A (1986) On the role of astrocytes in polyclonal T cell activation. J Neuroimmunol 10: 209–218
Schuller-Levis GB, Kozlowski PB, Wisniewski HM (1986) Cyclosporin A treatment of an induced attack in a chronic relapsing model of experimental allergic encephalomyelitis. Clin Immunol Immunopathol 40: 244–252
Sobel RA, Blanchette BW, Bhan AK, Colvin RB (1984) The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ. J Immunol 132: 2393–2401
Steinman L, Rosenbaum JT, Sriram S, McDevitt HO (1981) In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci USA 78: 7111–7114
Stone SH, Traugott U, Raine CS (1983) Chronic experimental allergic encephalomyelitis in strain 2 guinea pigs: absence of resistance to nervous system changes and sex dependence of clinical disease. J Neuroimmunol 4:187–199
Traugott U, Stone SH, Raine CS (1979) Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals. J Neurol Sci 41:17–29
Traugott U, Shevach E, Chiba J, Stone SH, Raine CS (1982) Chronic relapsing experimental allergic encephalomyelitis: identification and dynamics of T and B cells within the central nervous system. Cell Immunol 68:261–275
Vandenbark AA, Raus JCM (eds) (1984) Immunoregulatory processes in experimental allergic encephalomyelitis and multiple sclerosis. Research monographs in immunology. Elsevier, Amsterdam
Waldor MK, Sriram S, Hardy R, Herzenberg LA, Herzenberg LA, Lanier L, Lim M, Steinman L (1985) Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 227: 415–417
Waxman FJ, Taguiam JM, Whitacre CC (1984) Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine. Cell Immunol 85: 82–93
Weigle WO (1980) Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol 30:159–273
Wiesinger D, Borel JF (1980) Studies on the mechanism of action of cyclosporin A. Immunology 156: 454–463
Willenborg DO, Sjollema P, Danta G (1986) Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis. J Neuroimmunol 11:93–103
Wisniewski HM, Madrid RE (1983) Chronic progressive experimental allergic encephalomyelitis (EAE) in adult guinea pigs. J Neuropathol Exp Neurol 42: 243–255
Zamvil S, Nelson P, Trotter J, Mitchell D, Knobler R, Fritz R, Steinman L (1985) T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317: 355–358
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ryffel, B. (1988). Experimental Allergic Encephalomyelitis, Rat. In: Jones, T.C., Mohr, U., Hunt, R.D. (eds) Nervous System. Monographs on Pathology of Laboratory Animals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83516-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-83516-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83518-6
Online ISBN: 978-3-642-83516-2
eBook Packages: Springer Book Archive